Sale of Brust-Zentrum Zürich to Affidea

Sector(s)
Healthcare
Deal type
Sell your business
Date
April 2022
Countries involved
Switzerland / Netherlands

Client

Brust-Zentrum Zürich is a medical provider offering integrated services in women's health (breast cancer screening, diagnostic imaging...)

Deal

Capitalmind has advised the shareholders of Brust-Zentrum Zürich on the sale of a majority stake to Affidea

Parties

Lead team

  • Markus Decker

    Markus Decker

    Managing Partner Switzerland
  • Steven Brosi

    Steven Brosi

    Manager Switzerland
  • Yanik Costa

    Yanik Costa

    Manager Switzerland

About the deal

Brust-Zentrum Zürich is a highly reputed medical provider offering a wide range of integrated services in women’s health from breast cancer screening, diagnostic imaging, outpatient consultations, oncological medication treatment and surgical treatment. The clinic prides itself with a reputed team of 80 staff members and 20 breast specialists among which gynecologists, surgeons, oncologists, radiologists, complemented by genetic counseling specialist or psycho-oncologist, whose goal is to provide holistic care and support for patients with breast diseases.

Affidea Group, the largest European provider of diagnostic imaging, outpatient and cancer care services, has successfully completed the acquisition of a majority stake of Brust-Zentrum Zürich, the largest integrated breast medicine group in Switzerland with a leading market position in the canton of Zurich. With this partnership, Affidea Switzerland expands in the breast care market, offering integrated care services for women’s health, while at the same time enlarging its geographic footprint in the canton of Zurich. In Switzerland, the combined business of Affidea and Brust-Zentrum Zürich brings together more than 280 professionals in 11 centers, seeing more than 145.000 patients every year.

What we did

Capitalmind has advised the shareholders and the management team of Brust-Zentrum Zürich throughout the entire sale process: the development of a suitable transaction structure reflecting a complex shareholding situation, the formulation of a value-enhancing equity story providing strong synergies to buyers, the preparation of all marketing and process documents, the identification and approach of the relevant strategic/financial investors for a successful development of the company, the additional equity investment by several other key doctors, the preparation and organization of the due diligence as well as the negotiation of the commercial deal parameters until closing.

The CEO and co-owner of Brust-Zentrum Zürich, Prof. Christoph Tausch, commented: Capitalmind did a great job preparing and managing the entire process with their high quality advisory services and realising the transaction with Affidea with whom we have significant synergies for additional medical expertise and outstanding patient experience. My collaboration with Capitalmind was very close and I much appreciated their strong commitment to the project and their excellent expertise in the medical sector.”